Report Detail
Global Dengue Vaccines Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4670261 |
- 22 January, 2026 |
- Global |
- 69 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Dengue Vaccines market size was valued at US$ 608 million in 2025 and is forecast to a readjusted size of US$ 1502 million by 2032 with a CAGR of 14.0% during review period.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
This report is a detailed and comprehensive analysis for global Dengue Vaccines market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dengue Vaccines market size and forecasts, in consumption value ($ Million), 2021-2032
Global Dengue Vaccines market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Dengue Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Dengue Vaccines market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dengue Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dengue Vaccines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Dengvaxia
TAK-003
Others
Market segment by Application
Public Sector
Private Sector
Market segment by players, this report covers
Sanofi
Takeda
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Dengue Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dengue Vaccines, with revenue, gross margin, and global market share of Dengue Vaccines from 2021 to 2026.
Chapter 3, the Dengue Vaccines competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Dengue Vaccines market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dengue Vaccines.
Chapter 13, to describe Dengue Vaccines research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Dengue Vaccines by Type
- 1.3.1 Overview: Global Dengue Vaccines Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Dengue Vaccines Consumption Value Market Share by Type in 2025
- 1.3.3 Dengvaxia
- 1.3.4 TAK-003
- 1.3.5 Others
- 1.4 Global Dengue Vaccines Market by Application
- 1.4.1 Overview: Global Dengue Vaccines Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Public Sector
- 1.4.3 Private Sector
- 1.5 Global Dengue Vaccines Market Size & Forecast
- 1.6 Global Dengue Vaccines Market Size and Forecast by Region
- 1.6.1 Global Dengue Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Dengue Vaccines Market Size by Region, (2021-2032)
- 1.6.3 North America Dengue Vaccines Market Size and Prospect (2021-2032)
- 1.6.4 Europe Dengue Vaccines Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Dengue Vaccines Market Size and Prospect (2021-2032)
- 1.6.6 South America Dengue Vaccines Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Dengue Vaccines Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Sanofi
- 2.1.1 Sanofi Details
- 2.1.2 Sanofi Major Business
- 2.1.3 Sanofi Dengue Vaccines Product and Solutions
- 2.1.4 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Sanofi Recent Developments and Future Plans
- 2.2 Takeda
- 2.2.1 Takeda Details
- 2.2.2 Takeda Major Business
- 2.2.3 Takeda Dengue Vaccines Product and Solutions
- 2.2.4 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Dengue Vaccines Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Dengue Vaccines by Company Revenue
- 3.2.2 Top 3 Dengue Vaccines Players Market Share in 2025
- 3.2.3 Top 6 Dengue Vaccines Players Market Share in 2025
- 3.3 Dengue Vaccines Market: Overall Company Footprint Analysis
- 3.3.1 Dengue Vaccines Market: Region Footprint
- 3.3.2 Dengue Vaccines Market: Company Product Type Footprint
- 3.3.3 Dengue Vaccines Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Dengue Vaccines Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Dengue Vaccines Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Dengue Vaccines Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Dengue Vaccines Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Dengue Vaccines Consumption Value by Type (2021-2032)
- 6.2 North America Dengue Vaccines Market Size by Application (2021-2032)
- 6.3 North America Dengue Vaccines Market Size by Country
- 6.3.1 North America Dengue Vaccines Consumption Value by Country (2021-2032)
- 6.3.2 United States Dengue Vaccines Market Size and Forecast (2021-2032)
- 6.3.3 Canada Dengue Vaccines Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Dengue Vaccines Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Dengue Vaccines Consumption Value by Type (2021-2032)
- 7.2 Europe Dengue Vaccines Consumption Value by Application (2021-2032)
- 7.3 Europe Dengue Vaccines Market Size by Country
- 7.3.1 Europe Dengue Vaccines Consumption Value by Country (2021-2032)
- 7.3.2 Germany Dengue Vaccines Market Size and Forecast (2021-2032)
- 7.3.3 France Dengue Vaccines Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Dengue Vaccines Market Size and Forecast (2021-2032)
- 7.3.5 Russia Dengue Vaccines Market Size and Forecast (2021-2032)
- 7.3.6 Italy Dengue Vaccines Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Dengue Vaccines Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Dengue Vaccines Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Dengue Vaccines Market Size by Region
- 8.3.1 Asia-Pacific Dengue Vaccines Consumption Value by Region (2021-2032)
- 8.3.2 China Dengue Vaccines Market Size and Forecast (2021-2032)
- 8.3.3 Japan Dengue Vaccines Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Dengue Vaccines Market Size and Forecast (2021-2032)
- 8.3.5 India Dengue Vaccines Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Dengue Vaccines Market Size and Forecast (2021-2032)
- 8.3.7 Australia Dengue Vaccines Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Dengue Vaccines Consumption Value by Type (2021-2032)
- 9.2 South America Dengue Vaccines Consumption Value by Application (2021-2032)
- 9.3 South America Dengue Vaccines Market Size by Country
- 9.3.1 South America Dengue Vaccines Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Dengue Vaccines Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Dengue Vaccines Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Dengue Vaccines Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Dengue Vaccines Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Dengue Vaccines Market Size by Country
- 10.3.1 Middle East & Africa Dengue Vaccines Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Dengue Vaccines Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Dengue Vaccines Market Size and Forecast (2021-2032)
- 10.3.4 UAE Dengue Vaccines Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Dengue Vaccines Market Drivers
- 11.2 Dengue Vaccines Market Restraints
- 11.3 Dengue Vaccines Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Dengue Vaccines Industry Chain
- 12.2 Dengue Vaccines Upstream Analysis
- 12.3 Dengue Vaccines Midstream Analysis
- 12.4 Dengue Vaccines Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Dengue Vaccines. Industry analysis & Market Report on Dengue Vaccines is a syndicated market report, published as Global Dengue Vaccines Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Dengue Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
